(Date:11/30/2009)...and LOS ANGELES, Nov. 30 /PRNewswire-Asia-FirstCal...letin Board: CYXN; ,China Yongxin,Pharmaceuticals,...butor and,retailer of pharmaceuticals in Northeast...ation for distribution of medicines on the Essenti...cently formalized the nation,s Essential Drug,List...
(Date:11/30/2009)...PRNewswire-FirstCall/ -- BioMarin Pharmaceutical I... and Drug Administration (FDA) has granted orphan ..., amifampridine phosphate, for the rare autoimmune... 3,4-DAP has previously received orphan drug desi...mmittee for Medicinal Products for Human Use of th...
(Date:11/30/2009)...PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (...ts new class of platinum-based anti-tumor compound...anti-tumor potency and activity compared to curren...the ability to overcome cisplatin-resistance in ca...paper titled "Novel Bis-platinum Complexes Endowed...
(Date:11/30/2009)...30 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: W...medical-device research and,development outsourcin...States,announced that it had been selected to the...he fifth consecutive year. The list recognizes the...y, media, and telecommunications,industries based ...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2... High Throughput SNP Discovery Brings Expertise in...4 BioNanomatrix, Inc., a developer,of breakthroug...sonalized,medicine and biomedical research, today ...s researcher Pui-Yan Kwok, M.D., Ph.D., to its Sci...chrach Distinguished Professor at,the University o...
...ina, Oct. 14 /Xinhua-PRNewswire/ -- WuXi PharmaTec...ical, biotechnology and,medical device research an...in China and the United States, today announced pr... the third quarter ended September 30, 2008,and up...: http://www.newscom.com/cgi-bin/prnh/20040705/CN...
... Ill. --- Nanotechnology offers unique opportuniti...e delivery, manipulation and observation of biolog...ability to pattern nanoscale arrays of biological ...nd cell adhesion, and may be applied to achieve in...detection, even when sample volumes are severely l...
Other Biology Technology:BioNanomatrix Announces Appointment of Dr. Pui-Yan Kwok to Its Scientific Advisory Board 2WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 2WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 3WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 4WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 5WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 6WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 7WuXi PharmaTech Announces Preliminary Third Quarter 2008 Results and Updates 2008 Guidance 8Researchers write protein nanoarrays using a fountain pen and electric fields 2Researchers write protein nanoarrays using a fountain pen and electric fields 3Sentrix Custom-96 Expression Array Matrix (1) from Illumina
Mouse Anti-SERCA 1 ATPase Monoclonal Antibody, Unconjugated, Clone IIH11 from Novus Biologicals
AcroPrep 96 Filter Plates, 1 mL from Pall Life Sciences
HyQ SFX-Insect MP (1 x 5 L powder) from Hyclone
Biology Products: